MAPT and Alzheimer disease: Thus, like amyloid-targeting transgenic models, human tau with one or more familial AD-associated mutations, predominantly P301L or P301S mutations, are instead overexpressed to induce high levels of hyperphosphorylated tau and consequently neurodegeneration [127,128,129,130,131,132].